Trial
NCT03184415
Efficacy and Safety of DWC20155/DWC20156 Combination Therapy in Patients With Gastritis
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Daewoong Pharmaceutical Co. LTD.
Collaborators
—
Condition
Gastritis
Intervention
DWC20155
Why stopped
lack of efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-06-26